| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 1696 | 2023 |
| Mitochondrial dysfunction and oxidative stress in metabolic disorders—A step towards mitochondria based therapeutic strategies JS Bhatti, GK Bhatti, PH Reddy Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1863 (5 …, 2017 | 1404 | 2017 |
| Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management PS Rawat, A Jaiswal, A Khurana, JS Bhatti, U Navik Biomedicine & Pharmacotherapy 139, 111708, 2021 | 627 | 2021 |
| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 449 | 2023 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 438 | 2024 |
| Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives JS Bhatti, A Sehrawat, J Mishra, IS Sidhu, U Navik, N Khullar, S Kumar, ... Free Radical Biology and Medicine 184, 114-134, 2022 | 420 | 2022 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 415 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 409 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 402 | 2024 |
| Protective effects of Indian spice curcumin against amyloid-β in Alzheimer’s disease PH Reddy, M Manczak, X Yin, MC Grady, A Mitchell, S Tonk, CS Kuruva, ... Journal of Alzheimer's Disease 61 (3), 843-866, 2018 | 353 | 2018 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 252 | 2024 |
| Chapter 3 - MicroRNAs as peripheral biomarkers in aging and age-related diseases S Kumar, M Vijayan, JS Bhatti, PH Reddy Progress in molecular biology and translational science 146, 47-94, 2017 | 237 | 2017 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 179 | 2024 |
| Emerging role of non‐coding RNA in health and disease GK Bhatti, N Khullar, IS Sidhu, US Navik, AP Reddy, PH Reddy, JS Bhatti Metabolic brain disease 36, 1119-1134, 2021 | 166 | 2021 |
| Lifestyle modifications and nutritional interventions in aging-associated cognitive decline and Alzheimer’s disease GK Bhatti, AP Reddy, PH Reddy, JS Bhatti Frontiers in aging neuroscience 11, 369, 2020 | 141 | 2020 |
| Ameliorative action of melatonin on oxidative damage induced by atrazine toxicity in rat erythrocytes JS Bhatti, IPS Sidhu, GK Bhatti Molecular and cellular biochemistry 353, 139-149, 2011 | 89 | 2011 |
| Chapter 5 - MicroRNAs, aging, cellular senescence, and Alzheimer's disease PH Reddy, J Williams, F Smith, JS Bhatti, S Kumar, M Vijayan, ... Progress in molecular biology and translational science 146, 127-171, 2017 | 88 | 2017 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The Lancet 403 (10440), 2057-2099, 2024 | 84 | 2024 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, ... The Lancet Neurology 23 (10), 973-1003, 2024 | 70 | 2024 |
| Chapter 2 - Therapeutic strategies for mitochondrial dysfunction and oxidative stress in age-related metabolic disorders JS Bhatti, S Kumar, M Vijayan, GK Bhatti, PH Reddy Progress in molecular biology and translational science 146, 13-46, 2017 | 69 | 2017 |
P. Hemachandra ReddyTexas Tech Health Sciences CenterEmail verificata su ttuhsc.edu